Pathogen-associated molecular patterns (PAMPs) (PAMPs)

Pathogen-associated molecular patterns (PAMPs) are a diverse set of conserved molecular structures produced by microorganisms, including bacteria, viruses, fungi, and protozoa, which are recognized by the host's innate immune system (Janeway & Medzhitov, 2002, Annu Rev Immunol). These components, such as lipopolysaccharides (LPS) in Gram-negative bacteria, peptidoglycan in Gram-positive bacteria, and beta-glucans in fungi, are essential for microbial survival and are not found in host cells. In clinical medicine, PAMPs serve as critical targets for both diagnostic biomarkers and therapeutic interventions. For example, Polymyxin B exerts its effect by binding directly to the lipid A portion of LPS, while antifungal agents like Caspofungin target the synthesis of fungal cell wall glucans (StatPearls, "Antifungal Medications"). However, the rapid release of these components during treatment can trigger severe inflammatory responses, such as the Jarisch-Herxheimer reaction, posing significant therapeutic challenges. Because this entry describes a broad category of diverse molecules rather than a single specific receptor or enzyme, it is classified as a general target group rather than a discrete molecular target.

Other names

Microbial-associated molecular patternsMAMPsMicrobial cellular componentsExogenous pyrogensMicrobial signatures

Drugs targeting these components typically act by direct binding and sequestration (e.g., Polymyxins binding LPS), inhibition of biosynthesis (e.g., Echinocandins inhibiting beta-glucan synthesis), or non-specific oxidative/physical disruption of the microbial structure (e.g., antiseptics).